Tissue Plasminogen Activator and Stroke: Review of the Literature for the Clinician
- 31 December 2012
- journal article
- review article
- Published by Elsevier BV in The Journal of Emergency Medicine
- Vol. 43 (6), 1149-1154
- https://doi.org/10.1016/j.jemermed.2012.05.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Provider perceptions of barriers to the emergency use of tPA for Acute Ischemic Stroke: A qualitative studyBMC Emergency Medicine, 2011
- Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic StrokeStroke, 2009
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeThe New England Journal of Medicine, 2008
- Use of Thrombolysis in Acute Ischemic Stroke: Analysis of the Nationwide Inpatient Sample 1999 to 2004Annals of Emergency Medicine, 2007
- Guidelines for the Early Management of Adults With Ischemic StrokeStroke, 2007
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical PracticeStroke, 2003
- Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic StrokeStroke, 2003
- Systematic review of evidence on thrombolytic therapy for acute ischaemic strokeThe Lancet, 1997